Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.64 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.64 |
| ▸ | GAA | P10253 | 1/20 | 0.64 |
| ▸ | TSHR | P16473 | 1/20 | 0.64 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.64 |
| ▸ | HTT | P42858 | 1/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.53 |
| ▸ | MEN1 | O00255 | 4/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.51 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.46 |
| ▸ | SRR | Q9GZT4 | 1/20 | 0.46 |
| ▸ | PSAT1 | Q9Y617 | 1/20 | 0.46 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.46 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.45 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL8692226 | 0.98 | LMNA (0.62) | LMNAABCC4GAATSHRPTGS1 | |
| SCHEMBL2732935 | 0.94 | LMNA (0.54) | LMNAABCC4GAATSHRPTGS1 | |
| SCHEMBL41907 | 0.87 | CES1 (0.58) | LMNAABCC4GAATSHRPTGS1 | |
| SCHEMBL3426193 | 0.87 | CA2 (0.46) | LMNAABCC4GAATSHRPTGS1 | |
| Bromide SCHEMBL11497452 | 0.85 | CES1 (0.56) | LMNAABCC4GAATSHRPTGS1 | |
| Hydrochloric Acid SCHEMBL27862997 | 0.85 | CES1 (0.56) | LMNAABCC4GAATSHRPTGS1 | |
| SCHEMBL27564061 | 0.85 | CES1 (0.56) | LMNAABCC4GAATSHRPTGS1 | |
| SCHEMBL8692222 | 0.85 | LMNA (0.60) | LMNAABCC4GAATSHRPTGS1 | |
| SCHEMBL4806417 | 0.85 | CTBP2 (0.51) | LMNAABCC4GAATSHRPTGS1 | |
| SCHEMBL4808967 | 0.85 | CTBP2 (0.51) | LMNAABCC4GAATSHRPTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 598 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4073080-B1 | PROCESS FOR INDUSTRIAL PREPARATION OF THE DISODIUM SALT OF ((2S)-3-([1,1'-BIPHENYL]-4-YL)-2-((HYDROXY((1R)-1-(((1-(ISOBUTYRYLOXY)ETHOXY)CARBONYL)AMINO)ETHYL)PHOSPHORYL)METHYL)PROPANOYL)-L-ALANINE | KOS THERAPEUTICS INC (US) | 2023-10-11 | — | — | EP | claimed |
| US-20230041504-A1 | METHOD FOR THE INDUSTRIAL PREPARATION OF THE DISODIUM SALT OF ((2S)-3-([1,1'-BIPHENYL]-4-YL)-2-((HYDROXY((1R)-1-(((1-(ISOBUTYRYLOXY)ETHOXY)CARBONYL)AMINO)ETHYL)PHOSPHORYL) METHYL)PROPANOYL)-L-ALANINE | KOS THERAPEUTICS, INC. | 2023-02-09 | — | — | US | claimed |
| CN-114787171-A | Industrial process for the preparation of the disodium salt of ((2S) -3- ([1, 1' -biphenyl ] -4-yl) -2- ((hydroxy ((1R) -1- (((1- (isobutyroyloxy) ethoxy) carbonyl) amino) ethyl) phosphoryl) methyl) propionyl) -L-alanine | 领先药物公司 | 2022-07-22 | — | — | CN | claimed |
| WO-2021116617-A1 | PROCESS FOR INDUSTRIAL PREPARATION OF THE DISODIUM SALT OF ((2S)-3-([1,1'-BIPHENYL]-4-YL)-2-((HYDROXY((1R)-1-(((1-(ISOBUTYRYLOXY)ETHOXY)CARBONYL)AMINO)ETHYL)PHOSPHORYL)METHYL)PROPANOYL)-L-ALANINE | PHARMALEADS (FR) | 2021-06-17 | — | — | WO | claimed |
| US-20090017195-A1 | CURABLE ENCAPSULANT COMPOSITION AND ASSOCIATED METHOD | CITIBANK, N.A., AS COLLATERAL AGENT | 2009-01-15 | — | — | US | claimed |
| EP-1831285-A1 | CURABLE ENCAPSULANT COMPOSITION AND METHOD FOR PREPARING IT | General Electric Company (US) | 2007-09-12 | — | — | EP | claimed |
| WO-2006068728-A1 | CURABLE ENCAPSULANT COMPOSITION AND METHOD FOR PREPARING IT | GENERAL ELECTRIC COMPANY (US) | 2006-06-29 | — | — | WO | claimed |
| US-20060135705-A1 | melting at least a portion of pellets or powder, the portion comprising a mixture of a functionalized polymer and a reactive monomer andflowing the molten portion into contact with the portion of the electronic or optical device | GENERAL ELECTRIC COMPANY | 2006-06-22 | — | — | US | claimed |
| US-5549807-A | Thermoplastic composites formed by electropolymerization of N-substituted methacrylamide monomers | THE UNIVERSITY OF CONNECTICUT (US) | 1996-08-27 | — | — | US | claimed |
| US-5238542-A | Onto electrically conductive filler | THE UNIVERSITY OF CONNECTICUT (US) | 1993-08-24 | — | — | US | claimed |
| EP-0407773-A2 | Improved holographic notch filters | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-01-16 | — | — | EP | claimed |
| EP-0404099-A2 | Improved holographic optical combiners for head-up displays | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1990-12-27 | — | — | EP | claimed |
| EP-0404098-A2 | Holographic optical elements having a reflection hologram formed in a photopolymer | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1990-12-27 | — | — | EP | claimed |
| US-4965152-A | PHOTOPOLYMER FILMS IMAGED TO CONTAIN REFLECTION MIRROR | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1990-10-23 | — | — | US | claimed |
| US-4950567-A | Holographic optical combiners for head-up displays | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1990-08-21 | — | — | US | claimed |
| US-4942102-A | MULTILAYER OPTICAL ELEMENT, BINDER OF POLYVINYL ACETAL, AN UNSATURATED MONOMER AND A PHOTOINITIATOR | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1990-07-17 | — | — | US | claimed |
| EP-3216838-B1 | COMPOSITE SYSTEM WITH MASKING MATERIAL HAVING LOW ADHESION | TESA SE (DE) | 2026-04-01 | — | — | EP | disclosed |
| WO-2026047156-A1 | POLY(METH)ACRYLATES, PRESSURE-SENSITIVE ADHESIVE COMPOUNDS, AND METHOD FOR THE PRODUCTION THEREOF | TESA SE (DE) | 2026-03-05 | — | — | WO | disclosed |
| EP-0254032-A2 | Neutral metalloendopeptidase inhibitors in the treatment of hypertension | SCHERING CORPORATION (US) | 1988-01-27 | — | — | EP | disclosed |
| EP-0212440-A2 | Radiation-sensitive composition, registration material containing such a composition and process for the production of relief images | HOECHST AKTIENGESELLSCHAFT (DE) | 1987-03-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230041504-A1 | METHOD FOR THE INDUSTRIAL PREPARATION OF THE DISODIUM SALT OF ((2S)-3-([1,1'-BIPHENYL]-4-YL)-2-((HYDROXY((1R)-1-(((1-(ISOBUTYRYLOXY)ETHOXY)CARBONYL)AMINO)ETHYL)PHOSPHORYL) METHYL)PROPANOYL)-L-ALANINE | CHAMP1, AADAT, PTMS | LMNA 2343/4885ABCC4 3820/4885GAA 1354/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.